BIOTECHNOLOGY MARKET ANALYSIS

Biotechnology Market, By Application (Biopharmaceutical, Bio services, Bio-Agriculture, Research), By Technology (Fermentation, Tissue engineering, PCR technology, Nanobiotechnology, Chromatography, DNA Sequencing Technology, Cell Based Assay, Other Technologies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : Jul 2023
Code : CMI4025
Pages :160
Formats :
Excel and PDF
Industry : Biotechnology

Regional Analysis

Global Biotechnology Market - Regional Analysis

Among region, North America is estimated to hold a dominant position in the global biotechnology market over the forecast period, owing to increasing launches of products. For instance, on February 11, 2022, Eli Lilly and Company, a U.S.-based pharmaceutical company, received U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for bebtelovimab, an antibody that demonstrates neutralization against the Omicron variant. Bebtelovimab is used for the treatment of mild to moderate COVID-19 in adults and pediatric patients. The authorized dose of bebtelovimab is 175 mg given as an intravenous injection over at least 30 seconds.

Geographies covered:

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa